In pancreatic cancer setting, BRG1 exhibits both tumor-suppressive and tumor-promoted roles at distinct stages of pancreatic cancer formation, presenting a cellular context-dependent manner. This evidence concerns the gene SMARCA4 and familial pancreatic carcinoma.